Cary, N.C., April 29, 2008 – MicroMass Communications announced today the election of two new members to its board of directors—David Brinkley and Michael Bego. The NC-based agency is leader in behavioral science-based relationship marketing in the healthcare industry.

“It is an honor to welcome these gentlemen to our board of directors,” said Jay Bigelow, president of MicroMass. “Both David and Mike bring added experience and knowledge, and will work with the executive team to help us execute our growth plans.”

David Brinkley joins the board as an independent director. Brinkley is a seasoned pharmaceutical executive with deep experience in both business development and marketing in the pharmaceutical industry. Most recently as senior vice president, commercial development for Theravance Inc., a biopharmaceutical company located in South San Francisco, Brinkley is responsible for business development, new product planning/commercial development, marketing and corporate communications. Prior to that, he was director and worldwide team leader at Pfizer. There he was responsible for the global launch and marketing of the Viagra brand. His work on the Viagra launch has been recognized by Advertising Age as among the Top Ten Marketing Ideas of the Decade.

“David’s proven track record in pharmaceutical brand marketing is extremely valuable to us as we continue to aggressively expand our market leadership,” said Bigelow. “His perspective and insights will be true assets as we continue to develop and broaden the reach of our behavioral-based marketing solutions.”

“The marriage of MicroMass’ science based relationship marketing with their expertise in healthcare provides a unique service, unlike anything I have seen in the industry today,” said Brinkley. “It’s a privilege and important responsibility to be a member of the board of this progressive company.”

Michael Bego, manager at Willowridge Partners, joins the MicroMass board as an investor representative. Mike joined Willowridge in 2005 from McKinsey & Company and has consulted clients in the in the pharmaceutical, industrial, and financial industries.

“Mike’s business management expertise and credentials will add great value as we continue to expand the reach of our business strategies,” said Bigelow. “I look forward to his collaboration with the board and management team as we continue to position the agency for long-term success.”